Atrioventricular Block clinical trials

Explore recruiting atrioventricular block clinical trials.

Recruiting atrioventricular block studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Atrioventricular Block trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

InSaKa trial: Insulin dextrose infusion versus nebulized salbutamol versus combination of salbutamol and insulin dextrose in acute hyperkalemia: a randomized clinical trial

France

Therapeutic use (Phase IV) EU CTIS Study details

Pulse corticosteroids or/and Immunoglobulins to treat fulminant Myocarditis: a double-blind randomized controlled adaptive trial (The CORIUM study)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Optimized pharmacological treatment for broken heart (takotsubo) syndrome

Sweden, Denmark, Norway

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy (ACT-EARLY OLE)

Germany, Portugal, Netherlands, France, Spain, Italy +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

The effect of early Landiolol in patients with ST-elevation acute coronary syndrome undergoing primary percutaneous coronary intervention – A prospective, randomized, double- blinded, placebo controlled, phase IV pilot trial (STEMILAND-1)

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Atrioventricular Block trials by city

Atrioventricular Block in Toronto Atrioventricular Block in Vancouver Atrioventricular Block in Montreal Atrioventricular Block in Calgary Atrioventricular Block in Edmonton Atrioventricular Block in Ottawa Atrioventricular Block in Winnipeg Atrioventricular Block in Quebec City Atrioventricular Block in Hamilton Atrioventricular Block in Kitchener Atrioventricular Block in London Atrioventricular Block in Halifax Atrioventricular Block in New York Atrioventricular Block in Los Angeles Atrioventricular Block in Chicago Atrioventricular Block in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease